Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fosfomycin Calcium in Adult Women With Uncomplicated Urinary Tract Infection
2024-518646-24-00Phase 4Authorised
- Sponsor
- Bioaraba
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fosfomycin in urinary tract infection (UTI) (2 arms), sponsored by Bioaraba. Primary endpoint: Clinical and microbiological response at test-of-cure (TOC) visit. Planned start Dec 2024; status: authorised.
02
Drugs
fosfomycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2024-518646-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518646-24-00.